ArticleScientific reports2021

A bispecific antibody agonist of the IL-2 heterodimeric receptor preferentially promotes in vivo expansion of CD8 and NK cells.

Katherine E Harris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.